Latest Multiple myeloma Podcast Episodes
The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson
HealthTree Podcast for Multiple Myeloma - January 09, 2024 17:00 - 1 hour ★★★★★ - 13 ratingsThe year 2024 brings new promise in multiple myeloma with a wide variety of treatment options avaiable for both newly diagnosed and relapsed/refractory patients. Learn about the progress being made and the very latest in determining risk at diagnosis, strategies for smoldering myeloma patients, o...
Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB
HealthTree Podcast for Multiple Myeloma - October 27, 2023 18:00 - 1 hour ★★★★★ - 13 ratingsCAR T therapy is a highly effective treatment for myeloma patients, even in highly relapsed multiple myeloma. In today's show we will hear from Luciano Costa, MD of the University of Burmingham who will do a deep dive into CAR T therapy in multiple myeloma to discuss how CAR T availability is imp...
Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber
HealthTree Podcast for Multiple Myeloma - September 22, 2023 18:00 - 1 hour ★★★★★ - 13 ratingsDr. Paul Richardson of the Dana Farber Cancer Institute shares a mid-year myeloma review of ASCO, EHA and upcoming International Myeloma Society findings of the fast-moving research being performed in myeloma. Updates will include the expanding world of bispecific antibodies that include one FDA-...
Stem Cell Transplant Advances and Use in the Age of Immunotherapy
HealthTree Podcast for Multiple Myeloma - September 20, 2023 15:00 - 1 hour ★★★★★ - 13 ratingsStem cell transplant remains a useful and widely used treatment for multiple myeloma. John DiPersio, MD, PhD of the Siteman Cancer Center at Washington University joins HealthTree Podcast for Multiple Myeloma to discuss stem cell transplant in myeloma, a new and better way to collect stem cells a...
Essential Research for Myeloma Cures with Faith Davies, NYU
HealthTree Podcast for Multiple Myeloma - August 30, 2023 17:00 - 1 hour ★★★★★ - 13 ratingsThe cure for multiple myeloma only happens with patient participation in research. In this episode, Faith Davies, MBBCh, MRCP, MD, FRCPath of the NYU Langone will share how research works in multiple myeloma, the various stages in clinical trials, the most critical steps that move curative therap...
The Utility of MRD Testing for Myeloma Patient Treatment and Outcomes
HealthTree Podcast for Multiple Myeloma - July 07, 2023 16:00 - 1 hour ★★★★★ - 13 ratingsMinimal Residual Disease (MRD) testing is a more sensitive way to test for remaining disease following myeloma treatment. Its use could change the way experts treat multiple myeloma now and in the future. MRD testing may help determine which patients should stay on treament or which patients are ...
Understanding Blood-Based Testing in Multiple Myeloma with Ola Landgren, MD, PhD
HealthTree Podcast for Multiple Myeloma - May 31, 2023 16:00 - 1 hour ★★★★★ - 13 ratingsA wave of blood-based tests are being researched for myeloma care, and for good reason. Patients love the idea of replacing the painful bone marrow biopsy with a blood-based test, especially if it is equally effective. In addition to being less time consuming and painful, blood-based testing coul...
A New "Moda" Targeting CD38 in Multiple Myeloma with Noa Biran, MD, John Theurer
HealthTree Podcast for Multiple Myeloma - February 01, 2023 21:00 - 1 hour ★★★★★ - 13 ratingsDr. Noa Biran of Hackensack University joins HealthTree Podcast for Multiple Myeloma to discuss a completely new approach targeting CD38, which is found on most myeloma cells. The drug called modafakusp alpha (formerly known as TAK-573) uses a new method of targeting CD38 by combining a monoclona...
Myeloma Innovations in 2023 - An Annual Review with Robert Orlowski, MD, PhD
HealthTree Podcast for Multiple Myeloma - January 17, 2023 20:30 - 1 hour ★★★★★ - 13 ratingsThere are significant advances being made in multiple myeloma and more so than in any other cancer. Join us for this annual show with Robert Orlowski, MD, PhD as we discuss the recent findings from the American Society of Hematology (ASH) meeting, key innovations being developed in myeloma and wh...
HealthTree Podcast for Multiple Myeloma: Teclistamab's Approval with Dr. Garfall
HealthTree Podcast for Multiple Myeloma - November 14, 2022 18:30 - 1 hour ★★★★★ - 13 ratingsTeclistamab is the first bispecific antibody to be FDA approved in mulitple myeloma. On this HealthTree Podcast for Multiple Myeloma episode, learn from Alfred Garfall, MD of the University of Pennsylvania about how it will be used in the clinic as an approved therapy. Our discussion will include...
HealthTree Podcast: Kidney Disease and Multiple Myeloma with Natalie Callander
HealthTree Podcast for Multiple Myeloma - October 31, 2022 19:00 - 1 hour ★★★★★ - 13 ratingsOver 40% of multiple myeloma patients deal with kidney disease during their multiple myeloma journey. Learn more from Natalie Callander, MD of the University of Wisconsin at Madison about how myeloma affects the kidneys, what else causes kidney damage, signs and symptoms to watch for, tips to pro...
New Maintenance Therapy Approaches for Newly Diagnosed Multiple Myeloma
HealthTree Podcast for Multiple Myeloma - October 21, 2022 15:00 - 1 hour ★★★★★ - 13 ratingsMaintenance therapy over the past several years has commonly included the use of Revlimid (lenalidomide) over a long period of time. Is more better? Does more maintenance therapy or certain combinations help extend remissions or help patients deepen their responses? Ashraf Badros, MD, of the Un...
HealthTree Podcast for Myeloma: Ashraf Badros, MD, University of Maryland
HealthTree Podcast for Multiple Myeloma - October 21, 2022 15:00 - 1 hour ★★★★★ - 13 ratingsMaintenance therapy over the past several years has commonly included the use of Revlimid (lenalidomide) over a long period of time. Is more better? Does more maintenance therapy or certain combinations help extend remissions or help patients deepen their responses? Ashraf Badros, MD, of the Un...
HealthTree Podcast for Multiple Myeloma: Paul Richardson, MD, Dana Farber
HealthTree Podcast for Multiple Myeloma - July 18, 2022 15:00 - 1 hour ★★★★★ - 13 ratingsMyeloma advancements are happening quickly. Learn more from Paul Richardson, MD of the Dana Farber Cancer Institute about the latest findings from two key summer conferences. Thanks to our episode sponsor, Glaxo Smith Kline
HealthTree Podcast for Myeloma: Jesus Berdeja, MD, Sarah Cannon on Allo CAR T
HealthTree Podcast for Multiple Myeloma - June 27, 2022 19:00 - 1 hour ★★★★★ - 13 ratingsCAR T therapies are expanding as multiple myeloma treatment options. In addition to the two currently FDA approved CAR T therapies (Abecma and Carvykti) which use a patient's own T cells in a production process, new allo (off-the-shelf) options are being developed in clinical trials. Dr. Jesus Be...
Myeloma Crowd Radio: Robert Orlowski, MD, PhD, MD Anderson on Myeloma in 2022
HealthTree Podcast for Multiple Myeloma - February 07, 2022 20:00 - 1 hour ★★★★★ - 13 ratingsDr. Robert Z. Orlowski joins Myeloma Crowd Radio to share a study to share the new innovations myeloma patients can expect in 2022. He will review the recent findings from the American Society of Hematology meeting and share what we can expect from new combination therapies, best options for newl...
HealthTree Podcast for Multiple Myeloma: Dr. Robert Orlowski on Myeloma in 2022
HealthTree Podcast for Multiple Myeloma - February 07, 2022 20:00 - 1 hour ★★★★★ - 13 ratingsDr. Robert Z. Orlowski joins Myeloma Crowd Radio to share a study to share the new innovations myeloma patients can expect in 2022. He will review the recent findings from the American Society of Hematology meeting and share what we can expect from new combination therapies, best options for newl...
HealthTree Podcast for Myeloma: Shaji Kumar, MD, Mayo Clinic on ETBs in Myeloma
HealthTree Podcast for Multiple Myeloma - January 06, 2022 17:00 - 51 minutes ★★★★★ - 13 ratingsA new approach in myeloma immunotherapies is in the works called Engineered Toxic Bodies (ETBs). Early on, Molecular Templates partnered with Takeda Oncology to begin development on an ETB therapy for multiple myeloma targeting CD38. Currently, Molecular Templates is moving this therapy forward. ...
Myeloma Crowd Radio: Shaji Kumar, MD, Mayo Clinic on ETBs in Myeloma
HealthTree Podcast for Multiple Myeloma - January 06, 2022 17:00 - 51 minutes ★★★★★ - 13 ratingsA new approach in myeloma immunotherapies is in the works called Engineered Toxic Bodies (ETBs). Early on, Molecular Templates partnered with Takeda Oncology to begin development on an ETB therapy for multiple myeloma targeting CD38. Currently, Molecular Templates is moving this therapy forward. ...
Myeloma Crowd Radio: Dan Vogl, MD, UPENN and Yulia Nefedova, MD, PhD, Wistar
HealthTree Podcast for Multiple Myeloma - January 05, 2022 18:00 - 1 hour ★★★★★ - 13 ratingsJoin Dr. Dan Vogl and Dr. Yulia Nefedova to understand more about a new oral treatment for multiple myeloma called tasquinimod. This is a treatment that targets the tumor microenvironment by targeting myeloid-derived suppressor cells (MDSCs). MDSCs are a variety of cells that expand during cancer...
HealthTree Podcast: Dan Vogl, MD, UPENN and Yulia Nefedova, MD, PhD, Wistar
HealthTree Podcast for Multiple Myeloma - January 05, 2022 18:00 - 1 hour ★★★★★ - 13 ratingsJoin Dr. Dan Vogl and Dr. Yulia Nefedova to understand more about a new oral treatment for multiple myeloma called tasquinimod. This is a treatment that targets the tumor microenvironment by targeting myeloid-derived suppressor cells (MDSCs). MDSCs are a variety of cells that expand during cancer...
Myeloma Crowd Radio: Elisabet Manasanch, MD, MD Anderson
HealthTree Podcast for Multiple Myeloma - October 27, 2021 19:00 - 1 hour ★★★★★ - 13 ratingsSmoldering myeloma is a precursor condition for the blood cancer multiple myeloma. There is hot debate about when and how to treat this precursor condition. Do you treat it like regular myeloma? Do you try to prevent progression? And if so, with which therapies? Dr. Elisabet Manasanch of the MD A...
HealthTree Podcast for Multiple Myeloma: Elisabet Manasanch, MD, MD Anderson
HealthTree Podcast for Multiple Myeloma - October 27, 2021 19:00 - 1 hour ★★★★★ - 13 ratingsSmoldering myeloma is a precursor condition for the blood cancer multiple myeloma. There is hot debate about when and how to treat this precursor condition. Do you treat it like regular myeloma? Do you try to prevent progression? And if so, with which therapies? Dr. Elisabet Manasanch of the MD A...
Myeloma Crowd Radio: Cristina Gasparetto, MD Duke University & Mark Newman, OD
HealthTree Podcast for Multiple Myeloma - October 04, 2021 22:00 - 1 hour ★★★★★ - 13 ratingsAll cancer therapies come with some type of side effect. One newly approved therapy called BLENREP, by GSK, is an antibody drug conjugate targeting BCMA that can cause a condition called keratopathy. Keratopathy is an eye condition that can be mild, so patients don't even know they have it, or it...
HealthTree Podcast: Cristina Gasparetto, MD Duke University & Mark Newman, OD
HealthTree Podcast for Multiple Myeloma - October 04, 2021 22:00 - 1 hour ★★★★★ - 13 ratingsAll cancer therapies come with some type of side effect. One newly approved therapy called BLENREP, by GSK, is an antibody drug conjugate targeting BCMA that can cause a condition called keratopathy. Keratopathy is an eye condition that can be mild, so patients don't even know they have it, or it...
Myeloma Crowd Radio: Peter Voorhees, MD, Levine Cancer Institute
HealthTree Podcast for Multiple Myeloma - May 18, 2021 14:00 - 1 hour ★★★★★ - 13 ratingsMyeloma experts are beginning to use antibodies in earlier lines of myeloma treatment, even for newly diagnosed patients. Learn what recent clinical trials are using antibody therapies such as daratumumab and isatuximab in early quad (four) drug combinations for newly diagnosed patients. Peter Vo...
HealthTree Podcast for Myeloma: Peter Voorhees, MD, Levine Cancer Institute
HealthTree Podcast for Multiple Myeloma - May 18, 2021 14:00 - 1 hour ★★★★★ - 13 ratingsMyeloma experts are beginning to use antibodies in earlier lines of myeloma treatment, even for newly diagnosed patients. Learn what recent clinical trials are using antibody therapies such as daratumumab and isatuximab in early quad (four) drug combinations for newly diagnosed patients. Peter Vo...
Myeloma Crowd Radio: Sascha Tuchman, MD, University of North Carolina
HealthTree Podcast for Multiple Myeloma - May 14, 2021 15:00 - 1 hour ★★★★★ - 13 ratingsAL Amyloidosis is a secondary condition that can occur in patients with multiple myeloma and can cause protein buildup in organs like the heart, kidneys, liver and nerves. Join Myeloma Crowd Radio by HealthTree to hear from Sascha Tuchman, MD of the University of North Carolina at Chapel Hill as ...
HealthTree Podcast for Myeloma: Sascha Tuchman, MD, University of North Carolina
HealthTree Podcast for Multiple Myeloma - May 14, 2021 15:00 - 1 hour ★★★★★ - 13 ratingsAL Amyloidosis is a secondary condition that can occur in patients with multiple myeloma and can cause protein buildup in organs like the heart, kidneys, liver and nerves. Join HealthTree Podcast for Multiple Myeloma by HealthTree to hear from Sascha Tuchman, MD of the University of North Carolin...
HealthTree Podcast for Multiple Myeloma: Noopur Raje, MD, Mass General
HealthTree Podcast for Multiple Myeloma - April 16, 2021 18:00 - 1 hour ★★★★★ - 13 ratingsCAR T therapy has been in development for over 20 years. The first CAR T therapy is now available for the treatment of multiple myeloma. The ide-cel treatment (now called Abecma) is now FDA approved for multiple myeloma relapsed or refractory patients. In this show, Dr. Noopur Raje of Mass Genera...
Related Multiple myeloma Topics